company background image
FDA logo

Fidia BIT:FDA Stock Report

Last Price

€0.21

Market Cap

€6.7m

7D

-6.1%

1Y

-82.4%

Updated

30 Aug, 2024

Data

Company Financials

FDA Stock Overview

Designs, manufactures, and sells high speed milling systems, numerical controls, milling heads, and software systems.

FDA fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

Fidia S.p.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Fidia
Historical stock prices
Current Share Price€0.21
52 Week High€1.34
52 Week Low€0.21
Beta0.15
11 Month Change-34.56%
3 Month Change-71.62%
1 Year Change-82.39%
33 Year Change-91.19%
5 Year Change-95.02%
Change since IPO-98.41%

Recent News & Updates

It's Down 40% But Fidia S.p.A. (BIT:FDA) Could Be Riskier Than It Looks

Aug 29
It's Down 40% But Fidia S.p.A. (BIT:FDA) Could Be Riskier Than It Looks

Further Upside For Fidia S.p.A. (BIT:FDA) Shares Could Introduce Price Risks After 28% Bounce

Jun 20
Further Upside For Fidia S.p.A. (BIT:FDA) Shares Could Introduce Price Risks After 28% Bounce

Recent updates

It's Down 40% But Fidia S.p.A. (BIT:FDA) Could Be Riskier Than It Looks

Aug 29
It's Down 40% But Fidia S.p.A. (BIT:FDA) Could Be Riskier Than It Looks

Further Upside For Fidia S.p.A. (BIT:FDA) Shares Could Introduce Price Risks After 28% Bounce

Jun 20
Further Upside For Fidia S.p.A. (BIT:FDA) Shares Could Introduce Price Risks After 28% Bounce

Estimating The Fair Value Of Fidia S.p.A. (BIT:FDA)

May 28
Estimating The Fair Value Of Fidia S.p.A. (BIT:FDA)

Risks Still Elevated At These Prices As Fidia S.p.A. (BIT:FDA) Shares Dive 31%

Feb 13
Risks Still Elevated At These Prices As Fidia S.p.A. (BIT:FDA) Shares Dive 31%

Is Fidia (BIT:FDA) A Risky Investment?

Dec 23
Is Fidia (BIT:FDA) A Risky Investment?

Fidia S.p.A.'s (BIT:FDA) Business Is Trailing The Industry But Its Shares Aren't

Oct 04
Fidia S.p.A.'s (BIT:FDA) Business Is Trailing The Industry But Its Shares Aren't

Shareholder Returns

FDAIT MachineryIT Market
7D-6.1%1.1%1.8%
1Y-82.4%-8.0%15.4%

Return vs Industry: FDA underperformed the Italian Machinery industry which returned -8.8% over the past year.

Return vs Market: FDA underperformed the Italian Market which returned 14.4% over the past year.

Price Volatility

Is FDA's price volatile compared to industry and market?
FDA volatility
FDA Average Weekly Movement13.0%
Machinery Industry Average Movement3.7%
Market Average Movement4.1%
10% most volatile stocks in IT Market6.6%
10% least volatile stocks in IT Market2.5%

Stable Share Price: FDA's share price has been volatile over the past 3 months.

Volatility Over Time: FDA's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Italian stocks.

About the Company

FoundedEmployeesCEOWebsite
1974193Luigi Manigliowww.fidia.it

Fidia S.p.A., together with its subsidiaries, designs, manufactures, and sells high speed milling systems, numerical controls, milling heads, and software systems. Its accessories comprise HMS, a device for measuring and compensating geometric error on continuous or indexed bi-rotary heads and roto-tilting tables; TMSC, a device to measure length and diameter of the tool, as well as to check the shape; K5 tracer, a solution to perform continuous scanning of 3D surfaces; pushbutton panels; XPower digital drives for axis and spindle movement; and I/O Line input/output modules. The company’s software solutions include ViMill, an anti-collision solution; Machine Monitor, a software to monitor NC variables and parameters; Velocity 6, a solution for axes control to enhance the performances of the machine; HiMill, a CAM software for the machining of dies, models, and aeronautical components; Isograph solution, a user interface; and procedure-PRX, a solution for customized automation.

Fidia S.p.A. Fundamentals Summary

How do Fidia's earnings and revenue compare to its market cap?
FDA fundamental statistics
Market cap€6.65m
Earnings (TTM)-€1.31m
Revenue (TTM)€28.74m

0.2x

P/S Ratio

-5.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
FDA income statement (TTM)
Revenue€28.74m
Cost of Revenue€9.48m
Gross Profit€19.26m
Other Expenses€20.57m
Earnings-€1.31m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.042
Gross Margin67.03%
Net Profit Margin-4.55%
Debt/Equity Ratio180.7%

How did FDA perform over the long term?

See historical performance and comparison